About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

COMPLETEDPhase 1

Study to Evaluate the Pressor Effect of Oral Tyramine During Ozanimod Treatment in Healthy Adult Participants

A Phase 1, Randomized, Double-blind, Placebo- and Positive-controlled Study to Evaluate the Effect of Ozanimod on Pressor Response to Oral Tyramine in Healthy Adult Subjects

NCT04978298•Celgene

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Healthy Volunteers

Interventions

Placebo

Rasigiline

+2 more

Locations

1

United States

Locations (1)

Local Institution - 001

Anaheim, California, United States

Key Dates

Start Date

July 19, 2021

Primary Completion Date

February 26, 2023

Completion Date

February 26, 2023

Last Updated

August 31, 2023

Related Studies

Cytapheresis of Volunteer Donors

NCT00104325

Healthy Volunteers

RECRUITINGPhase 1/2

Study Evaluating ABCL635 for Vasomotor Symptoms of Menopause

NCT07118891

Vasomotor Symptoms Associated With MenopauseHealthy Volunteers

New Heart Imaging Techniques to Evaluate Possible Heart Disease

NCT01399385

HealthyObesity+3 more

RECRUITINGPhase 1

A Study to Evaluate ALN-4285 in Adult Healthy Volunteers

NCT07295717

Healthy Volunteers

A Technical Innovation of Prismatic Adaptation Test in Healthy Subject, in Favour of Autonomy and Independence in Daily Life Following a Brain Injury

NCT03807401

Healthy Volunteers

RECRUITINGPhase 1

A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7806881 in Healthy Participants

NCT07271693

Healthy Volunteers

View all related studies

Sponsors

Lead Sponsor

Celgene

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 31, 2023Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions